Why some health groups are banding together to push for a range of obesity-care options in workplace-sponsored insurance.

New trial data showed CagriSema led to “superior” weight loss, but at a rate much less than original expectations of 25%.

Impressions Face + Body owner says he's noticed a spike in interest from clients hoping to get face and body-lifts offered ...

Season three of The White Lotus is causing waves, especially for its uneasy female friend group. The three women at the ...

With GLP-1 weight loss comes muscle loss. Gyms and personal trainers are rising to the challenge to help people build it back ...

After years of weight loss drug shortages, the FDA is saying there’s now an adequate supply for most medications and they ...

Research suggests potential health benefits beyond what popular diabetes and weight-loss drugs were first approved to treat.

BRINP2-related peptide, or BRP, is a naturally occurring molecule that can suppress appetite and promote weight loss in mice ...

Altimmune said on Thursday that it plans to test its lead experimental obesity drug, pemvidutide, to potentially treat ...

When James Norris, a 56-year-old mechanic from Roxbury, New Jersey, went on a low dose of Mounjaro, a GLP-1 medication similar to Ozempic, to lose weight in March 2023, he thought it would be a ...

Like Aly, Abdul-Rahman also stresses that GLP-1 medications are a treatment for diabetes and obesity, and as such, they do ...

Despite the promising results, further research is needed before GLP-1 receptor agonists and dual GIP/GLP-1 receptor agonists ...